Provided by Tiger Trade Technology Pte. Ltd.

Harmony Biosciences Holdings, Inc.

40.83
+1.453.68%
Volume:426.51K
Turnover:17.21M
Market Cap:2.38B
PE:13.21
High:41.20
Open:39.38
Low:39.38
Close:39.38
52wk High:41.20
52wk Low:25.52
Shares:58.24M
Float Shares:50.80M
Volume Ratio:0.88
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.09
EPS(LYR):2.71
ROE:20.46%
ROA:11.62%
PB:2.38
PE(LYR):15.07

Loading ...

Harmony Biosciences to Join Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Aug 27

Harmony Biosciences Price Target Announced at $60.00/Share by Wolfe Research

Dow Jones
·
Aug 26

Harmony Biosciences: Strengthening Core Business and Pipeline Support Unchanged $55 Price Target and Buy Rating

TIPRANKS
·
Aug 12

Praxis Precision Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 06

Harmony Biosciences is Maintained at Hold by Truist Securities

Dow Jones
·
Aug 06

UBS Reaffirms Their Hold Rating on Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
Aug 05

Harmony Biosciences Says New Data Supports Neurology Pipeline

Benzinga Earnings
·
Aug 05

Harmony Biosciences price target raised to $30 from $28 at BofA

TIPRANKS
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Lemaitre Vascular (LMAT) and Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
Aug 05

Ultragenyx Q2 Revenue Rises 28% to Record High, Net Loss Narrows

Reuters
·
Aug 05

Rigel Pharmaceuticals Q2 Revenue Rises on Strong Product Demand

Reuters
·
Aug 05

Harmony Biosciences Shares Rise After Q2 Earnings, Product Revenue Increase

MT Newswires Live
·
Aug 04

Harmony Biosciences Holdings Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Harmony Biosciences Q2 WAKIX Revenue Beats on Patient Growth

Reuters
·
Aug 04

GUIDANCE: (HRMY) Harmony Biosciences Expects 2026 Wakix Net Revenue Range $1.0B to $1.04B

MT Newswires Live
·
Aug 04

Earnings Flash (HRMY) Harmony Biosciences Posts Q2 EPS $1.28, vs. FactSet Est of $0.96

MT Newswires Live
·
Aug 04

Harmony Biosciences Q2 EPS $1.28 Beats $0.94 Estimate, Sales $261.300M Beat $248.406M Estimate

Benzinga Earnings
·
Aug 04

Harmony Biosciences Q2 FY26 Net Income Rises 90% to $75.4 Million; Revenue Climbs 30% to $261.3 Million

Reuters
·
Aug 04

Harmony Biosciences : Mizuho Raises Target Price to $51 from $50

THOMSON REUTERS
·
Aug 03

Harmony Biosciences (HRMY) Stock Looks Below Fair Value On Earnings

Simply Wall St.
·
Aug 02